Is there a real risk of bacterial infection in patients receiving targeted and biological therapies? Ivan Noreña; Mario Fernández-Ruiz; José María Aguado;

Effects of COVID-19-Associated Pulmonary Aspergillosis (CAPA) on the prognosis of severe COVID-19: Clinical characteristics and risk factors in a second-level hospital from Southern Spain Javier Martínez de Victoria Carazo; Daniel Fernández Reyes; Adolfo de Salazar González; Miguel Ángel Montero Alonso; Purificación Fernández Morales; Federico García García; Fernando García García; Eugenia Yuste Ossorio; José Hernández Quero; Emilio Guirao Arrabal;

Oral involvement in mucormycosis. A retrospective study of 55 cases Alexandro Bonifaz; Andrés Tirado-Sánchez; Fernando Paredes-Farrera; Joaquín Moreno-Moreno; Javier Araiza; Gloria M. González;